Global Neurological Disorder Drugs Market Research Report 2017

December 2017 | 106 pages | ID: GFE01A1D0E1EN
QYResearch

Abstracts

In this report, the global Neurological Disorder Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neurological Disorder Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Neurological Disorder Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Novartis AG
• GlaxoSmithKline plc
• Merck & Co.
• Bayer AG
• AstraZeneca
• Boehringer Ingelheim GmbH
• Teva Pharmaceutical Industries Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Clinic
• Home

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Neurological Disorder Drugs Market Research Report 2017

1 NEUROLOGICAL DISORDER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Neurological Disorder Drugs
1.2 Neurological Disorder Drugs Segment by Type (Product Category)
  1.2.1 Global Neurological Disorder Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Neurological Disorder Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Antipsychotic
  1.2.4 Hypnotic & Sedative
  1.2.5 Analgesics
  1.2.6 Anticoagulants
  1.2.7 Others
1.3 Global Neurological Disorder Drugs Segment by Application
  1.3.1 Neurological Disorder Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home
1.4 Global Neurological Disorder Drugs Market by Region (2012-2022)
  1.4.1 Global Neurological Disorder Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Neurological Disorder Drugs (2012-2022)
  1.5.1 Global Neurological Disorder Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Neurological Disorder Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neurological Disorder Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Neurological Disorder Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Neurological Disorder Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Neurological Disorder Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Neurological Disorder Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neurological Disorder Drugs Market Competitive Situation and Trends
  2.5.1 Neurological Disorder Drugs Market Concentration Rate
  2.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEUROLOGICAL DISORDER DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Neurological Disorder Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Neurological Disorder Drugs Production and Market Share by Region (2012-2017)
3.3 Global Neurological Disorder Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL NEUROLOGICAL DISORDER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Neurological Disorder Drugs Consumption by Region (2012-2017)
4.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neurological Disorder Drugs Production and Market Share by Type (2012-2017)
5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Neurological Disorder Drugs Price by Type (2012-2017)
5.4 Global Neurological Disorder Drugs Production Growth by Type (2012-2017)

6 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Neurological Disorder Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEUROLOGICAL DISORDER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis AG
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline plc
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Merck & Co.
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Merck & Co. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Bayer AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 AstraZeneca Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim GmbH
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Teva Pharmaceutical Industries Ltd.
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Neurological Disorder Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview

8 NEUROLOGICAL DISORDER DRUGS MANUFACTURING COST ANALYSIS

8.1 Neurological Disorder Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neurological Disorder Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neurological Disorder Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST (2017-2022)

12.1 Global Neurological Disorder Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Neurological Disorder Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2017-2022)
12.2 Global Neurological Disorder Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Neurological Disorder Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Neurological Disorder Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Disorder Drugs
Figure Global Neurological Disorder Drugs Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Neurological Disorder Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Antipsychotic
Table Major Manufacturers of Antipsychotic
Figure Product Picture of Hypnotic & Sedative
Table Major Manufacturers of Hypnotic & Sedative
Figure Product Picture of Analgesics
Table Major Manufacturers of Analgesics
Figure Product Picture of Anticoagulants
Table Major Manufacturers of Anticoagulants
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Neurological Disorder Drugs Consumption (K Pcs) by Applications (2012-2022)
Figure Global Neurological Disorder Drugs Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Examples
Table Key Downstream Customer in Home
Figure Global Neurological Disorder Drugs Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Neurological Disorder Drugs Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Neurological Disorder Drugs Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Neurological Disorder Drugs Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Neurological Disorder Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Neurological Disorder Drugs Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Neurological Disorder Drugs Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Neurological Disorder Drugs Major Players Product Production (K Pcs) (2012-2017)
Table Global Neurological Disorder Drugs Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Neurological Disorder Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Neurological Disorder Drugs Production Share by Manufacturers
Figure 2017 Neurological Disorder Drugs Production Share by Manufacturers
Figure Global Neurological Disorder Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Neurological Disorder Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Neurological Disorder Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table 2017 Global Neurological Disorder Drugs Revenue Share by Manufacturers
Table Global Market Neurological Disorder Drugs Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Neurological Disorder Drugs Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Neurological Disorder Drugs Product Category
Figure Neurological Disorder Drugs Market Share of Top 3 Manufacturers
Figure Neurological Disorder Drugs Market Share of Top 5 Manufacturers
Table Global Neurological Disorder Drugs Capacity (K Pcs) by Region (2012-2017)
Figure Global Neurological Disorder Drugs Capacity Market Share by Region (2012-2017)
Figure Global Neurological Disorder Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Neurological Disorder Drugs Capacity Market Share by Region
Table Global Neurological Disorder Drugs Production by Region (2012-2017)
Figure Global Neurological Disorder Drugs Production (K Pcs) by Region (2012-2017)
Figure Global Neurological Disorder Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Neurological Disorder Drugs Production Market Share by Region
Table Global Neurological Disorder Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Neurological Disorder Drugs Revenue Market Share by Region (2012-2017)
Figure Global Neurological Disorder Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Neurological Disorder Drugs Revenue Market Share by Region
Figure Global Neurological Disorder Drugs Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Neurological Disorder Drugs Consumption (K Pcs) Market by Region (2012-2017)
Table Global Neurological Disorder Drugs Consumption Market Share by Region (2012-2017)
Figure Global Neurological Disorder Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Neurological Disorder Drugs Consumption (K Pcs) Market Share by Region
Table North America Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Neurological Disorder Drugs Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Neurological Disorder Drugs Production (K Pcs) by Type (2012-2017)
Table Global Neurological Disorder Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Neurological Disorder Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Neurological Disorder Drugs by Type
Table Global Neurological Disorder Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Neurological Disorder Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Neurological Disorder Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Neurological Disorder Drugs by Type
Table Global Neurological Disorder Drugs Price (USD/Pcs) by Type (2012-2017)
Figure Global Neurological Disorder Drugs Production Growth by Type (2012-2017)
Table Global Neurological Disorder Drugs Consumption (K Pcs) by Application (2012-2017)
Table Global Neurological Disorder Drugs Consumption Market Share by Application (2012-2017)
Figure Global Neurological Disorder Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Neurological Disorder Drugs Consumption Market Share by Application in 2016
Table Global Neurological Disorder Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Neurological Disorder Drugs Consumption Growth Rate by Application (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure Novartis AG Neurological Disorder Drugs Production Market Share (2012-2017)
Figure Novartis AG Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline plc Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co. Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure Merck & Co. Neurological Disorder Drugs Production Market Share (2012-2017)
Figure Merck & Co. Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure Bayer AG Neurological Disorder Drugs Production Market Share (2012-2017)
Figure Bayer AG Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure AstraZeneca Neurological Disorder Drugs Production Market Share (2012-2017)
Figure AstraZeneca Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Market Share (2012-2017)
Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Production Market Share (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Disorder Drugs
Figure Manufacturing Process Analysis of Neurological Disorder Drugs
Figure Neurological Disorder Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2016
Table Major Buyers of Neurological Disorder Drugs
Table Distributors/Traders List
Figure Global Neurological Disorder Drugs Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Neurological Disorder Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Neurological Disorder Drugs Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Neurological Disorder Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Neurological Disorder Drugs Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Neurological Disorder Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Neurological Disorder Drugs Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Neurological Disorder Drugs Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Neurological Disorder Drugs Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Neurological Disorder Drugs Production (K Pcs) Forecast by Type (2017-2022)
Table Global Neurological Disorder Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Neurological Disorder Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Neurological Disorder Drugs Price Forecast by Type (2017-2022)
Table Global Neurological Disorder Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Neurological Disorder Drugs Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source